en 
Deutsch 
Española 
Italiano 
Français 
Polski 
Nederlands 
Svenska (Sverige) 
Czech (Čeština) 
EVIMED 60 (Raloxifene HCL)
• CAS number: 82640-04-8
• Molecular Weight: 510.00 g/mol
• Formula: C28H28ClNO4S
EVIMED 60 by DEUS MEDICAL®
EVIMED 60 (RALOXIFENE HCL)
Overview
EVIMED 60 (Raloxifene HCL) is a drug used by women to prevent and treat bone loss (osteoporosis) after menopause. It slows down bone loss and helps to keep bones strong, making them less likely to break. EVIMED 60 may also lower the chance of getting a certain type of breast cancer after menopause. EVIMED 60 is manufactured as 60mg tablets containing Raloxifene HCL 60mg and excipients.
Raloxifene Mechanism of Action
Raloxifene HCL belongs to a class of drugs known as selective estrogen receptor modulators-SERMs. It exhibits estrogenic activity in some tissues like the bone and liver, while it shows antiestrogenic activity in the breasts and uterus. In the bone, it increases bone density and that is why it is useful in treating osteoporosis. In the breast, it opposes estrogen activity, and this action is useful in the treatment and prevention of some types of breast cancers.
Raloxifene Dosage
60mg daily taken orally.
Raloxifene Side Effects
Hot flashes, Leg cramps, blood clots, vaginal dryness.
Raloxifene Interactions
Estrogen, cholestyramine, tibolone, and colestipol.
✓ Raloxifene HCL . . . . . . . . . . . . . 60mg
✓ Excipients . . . . . . . . . . . . . . . . . . . . . q.s
BECOME A PARTNER
We are offering a diverse range of pharmaceutical products, which are available only from an authorized resellers. Our highly-regarded partners are comprised of industry experts who share our values and commitment. Our goal is to strengthen our network of prestigious professionals who strive to deliver great quality products.
We believe that partnerships are essential to drive change, innovation and transformation, and we are committed to ensuring the success of our collaborations.